Newsweek

Culture Capitals: Two European Cities' Plans for 2017

Aarhus in Denmark and Kingston-upon-Hull in England plan yearlong celebrations of arts, spectacles and community events.
A performance of modern ballet Tree of Codes in Aarhus, Denmark.
01_20_HullAarhus_02

Although 450 miles of cold and choppy North Sea divide Aarhus, on the east coast of the Jutland peninsula in Denmark, and Kingston-upon-Hull on the northeast coast of England, the two ports have something in common. Stroll on both refurbished waterfronts and you feel the tides of change. In Hull, the futuristic, pointed prow of The Deep—an aquarium and ocean-research center—thrusts into the broad Humber estuary, while next to the marina, new arts venues and craft workshops are filling the sheds and stores of the old fruit market. On Aarhus’s newly smartened dockside, the dazzling, seven-sided Dokk1 looks like a spaceship, but it holds a state-of-the art library and cultural hub. The reason for all this activity? Both places are 2017 cities of culture.

: a competitive accolade first awarded to Athens in 1985, and now granted to two bidders every year. . The U.K. devised this domestic spin-off, held every four years, after the success of Glasgow and Liverpool as Europe’s Capitals of Culture in 1990 and 2008.

You’re reading a preview, subscribe to read more.

More from Newsweek

Newsweek12 min read
The Inconceivable Search For Sperm
SINGLE WOMEN AND LGBTQ+ COUPLES are increasingly pursuing pregnancy via known donors—people they find on the internet, in Facebook groups and through dating-like apps. In her own quest to become a solo mother by choice, investigative journalist Valer
Newsweek3 min read
Newsweek US
GLOBAL EDITOR IN CHIEF _ Nancy Cooper VICE PRESIDENT, DIGITAL _ Laura Davis DIRECTOR OF OPERATIONS _ Melissa Jewsbury OPINION EDITOR _ Batya Ungar-Sargon GLOBAL PUBLISHING EDITOR _ Chris Roberts SENIOR EDITOR-AT-LARGE _ Josh Hammer EDITORIAL Managi
Newsweek5 min read
‘Deadly Risk’ of Fat-Loss Drugs
“MIRACLE” FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned. The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2

Related